FDA Tightens Use of Contentious Alzheimer’s Drug

Published on July 8, 2021

U.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug. The Food and Drug Administration said the change is intended to address confusion among physicians and patients…

Read Full Article (External Site)